These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 7993839
1. Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine. Erba E, Giordano M, Danova M, Mazzini G, Ubezio P, Torri V, Mangioni C, Landoni F, Bolis P, Tenti P. Ann Oncol; 1994 Sep; 5(7):627-34. PubMed ID: 7993839 [Abstract] [Full Text] [Related]
2. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck]. Margarino G, Scala M, Schenone G, Mereu P, Corvo R, Sanguineti G, Giaretti W, Geido E, Orecchia R, Meszaros P. Acta Otorhinolaryngol Ital; 1992 Sep; 12(5):421-33. PubMed ID: 1303006 [Abstract] [Full Text] [Related]
3. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. Tsang RW, Fyles AW, Kirkbride P, Levin W, Manchul LA, Milosevic MF, Rawlings GA, Banerjee D, Pintilie M, Wilson GD. Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1319-29. PubMed ID: 7635771 [Abstract] [Full Text] [Related]
4. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. Corvò R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Barra S, Margarino G, Bacigalupo A, Vitale V. Int J Radiat Oncol Biol Phys; 1993 Dec 01; 27(5):1165-72. PubMed ID: 8262843 [Abstract] [Full Text] [Related]
6. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry. Benazzo M, Mevio E, Occhini A, Franchini G, Danova M. ORL J Otorhinolaryngol Relat Spec; 1995 Dec 01; 57(1):39-43. PubMed ID: 7700609 [Abstract] [Full Text] [Related]
7. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine]. Okuda Y, Taomoto K, Saya H, Ijichi A, Kudo H, Kokunai T, Tamaki N, Matsumoto S. No To Shinkei; 1989 Apr 01; 41(4):383-90. PubMed ID: 2765301 [Abstract] [Full Text] [Related]
10. Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry. Mazzini G, Danova M, Ferrari C, Giordano M, Dionigi P, Riccardi A. Anal Cell Pathol; 1996 Mar 01; 10(2):101-13. PubMed ID: 8721953 [Abstract] [Full Text] [Related]
11. Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study. Rew DA, Thomas DJ, Coptcoat M, Wilson GD. Br J Urol; 1991 Jul 01; 68(1):44-8. PubMed ID: 1873691 [Abstract] [Full Text] [Related]
12. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables. Tsang RW, Fyles AW, Li Y, Rajaraman MM, Chapman W, Pintilie M, Wong CS. Radiother Oncol; 1999 Jan 01; 50(1):85-92. PubMed ID: 10225561 [Abstract] [Full Text] [Related]
13. DNA-ploidy and proliferative activity in uterine-tumors - an in-vivo study using bromodeoxyuridine and flow-cytometry. Franchini G, Tusei A, Babilonti L, Donadello N, Franchi M, Zanaboni F, Tateo S, Mazzini G, Riccardi A, Danova M. Oncol Rep; 1994 Jan 01; 1(1):65-7. PubMed ID: 21607307 [Abstract] [Full Text] [Related]
14. Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance. Michel P, Paresy M, Lepessot F, Hellot MF, Paillot B, Scotte M, Peillon C, Ducrotté P, Hemet J. Eur J Gastroenterol Hepatol; 2000 Mar 01; 12(3):275-80. PubMed ID: 10750646 [Abstract] [Full Text] [Related]
15. Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot? Haustermans K, Fowler J, Geboes K, Christiaens MR, Lerut A, van der Schueren E. Radiother Oncol; 1998 Feb 01; 46(2):157-67. PubMed ID: 9510043 [Abstract] [Full Text] [Related]
16. Correlation of DNA ploidy and proliferative activity in human gastric cancer. Yonemura Y, Sugiyama K, Fujimura T, De Aretxabala X, Kamata T, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I. Cancer; 1988 Oct 15; 62(8):1497-502. PubMed ID: 3167767 [Abstract] [Full Text] [Related]
17. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate. Meyer JS, Gersell DJ, Yim S. Gynecol Oncol; 2001 Jun 15; 81(3):466-76. PubMed ID: 11371140 [Abstract] [Full Text] [Related]
18. Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling. Rostagno P, Moll JL, Birtwisle-Peyrottes I, Ettore F, Lagrange JL, Gioanni J, Caldani C. Anticancer Res; 1994 Jun 15; 14(5A):2025-32. PubMed ID: 7531416 [Abstract] [Full Text] [Related]
19. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers. Ohyama S, Yonemura Y, Miyazaki I. Cancer; 1990 Jan 01; 65(1):116-21. PubMed ID: 2293858 [Abstract] [Full Text] [Related]